+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Canine Atopic Dermatitis Market - Global Forecast 2026-2032- Product Image
Canine Atopic Dermatitis Market - Global Forecast 2026-2032- Product Image
Sale

Canine Atopic Dermatitis Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337468
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Canine Atopic Dermatitis Market is projected to reach USD 4.83 Billion in 2026. It is expected to continue growing at a CAGR of 6.31%, reaching USD 7.00 Billion by 2032.

Canine atopic dermatitis is a chronic, relapsing inflammatory and pruritic skin disease associated with genetic predisposition, impaired skin-barrier function, environmental allergens, microbial dysbiosis, and immune signaling. It is widely recognized in veterinary dermatology as one of the most common causes of persistent itching, recurrent otitis externa, paw licking, secondary bacterial or yeast infections, sleep disturbance, and reduced quality of life in dogs.

The canine atopic dermatitis market is advancing as pet owners increasingly treat dogs as family members and expect evidence-based, long-term dermatology care. Demand is strongest for solutions that reduce pruritus quickly, limit prolonged corticosteroid exposure, support year-round disease control, and integrate easily into routine veterinary workflows. This creates opportunities across prescription antipruritic therapies, biologics, Janus kinase inhibitors, immunomodulators, allergen-specific immunotherapy, medicated topicals, dermatology diagnostics, therapeutic nutrition, and digital monitoring tools.

Transformative Shifts in the Canine Atopic Dermatitis Landscape

The competitive landscape is shifting from episodic itch relief toward proactive, multimodal management of canine atopic dermatitis. Veterinarians increasingly combine targeted antipruritic therapy, antimicrobial stewardship, skin-barrier repair, allergen avoidance, nutritional support, parasite control, and client education to manage flares while reducing recurrence and secondary infection risk.

Innovation is also moving treatment decisions closer to the individual dog. Breed predisposition, age of onset, seasonality, lesion distribution, concurrent otitis, food allergy evaluation, ectoparasite exclusion, infection status, and prior treatment response are now central to therapy selection. Suppliers that support veterinarians with clear clinical pathways, adherence tools, practical dosing options, and robust safety evidence are better positioned than those competing on product availability alone.

Cumulative Impact of Artificial Intelligence on Veterinary Dermatology

Artificial intelligence is becoming a practical enabler in veterinary dermatology rather than a distant concept. Image analysis can support triage of skin lesions, digital intake tools can structure owner-reported itch scores, and predictive analytics can help identify dogs at higher risk of flare recurrence based on seasonality, medication history, lesion progression, and comorbid infections.

The cumulative impact of AI is strongest when it improves workflow efficiency and treatment continuity. Veterinary teams can use AI-assisted reminders, teledermatology documentation, inventory planning, clinical note structuring, and outcomes tracking to improve adherence and detect relapse earlier. However, clinical oversight remains essential because canine atopic dermatitis is a diagnosis of exclusion and requires assessment for parasites, infection, food allergy, contact reactions, and other pruritic diseases before long-term therapy is selected.

Key Regional Insights for Canine Atopic Dermatitis

North America remains a highly developed region for canine atopic dermatitis treatment due to advanced companion animal healthcare spending, broad access to veterinary specialists, pet insurance adoption, and strong use of prescription antipruritic therapies. Europe shows similar maturity, supported by established veterinary dermatology networks, regulated access to veterinary medicines, high standards for pharmacovigilance, and strong emphasis on antimicrobial stewardship in chronic skin disease management.

Asia-Pacific is gaining momentum as urban pet ownership, veterinary clinic expansion, premium pet care spending, and awareness of chronic allergic skin disease rise across China, Japan, South Korea, India, Australia, and Southeast Asia. Latin America, led by Brazil and Mexico, is benefiting from a growing companion animal base, expanding small animal practice capabilities, and increasing availability of modern dermatology products. The Middle East is developing through premium veterinary services in urban centers, particularly where imported medicines and specialist referral care are more accessible, while Africa remains more uneven, with activity concentrated in private clinics serving major cities and higher-income pet owners.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, canine atopic dermatitis demand is supported by expanding urban pet ownership, rising awareness of chronic pruritic skin disease, and improving access to small animal clinics in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is characterized by premium veterinary care demand across the United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Bahrain, and Oman, where imported therapies, dermatology consultations, and companion animal wellness services are increasingly visible in major urban markets.

The European Union offers a structured regulatory and clinical environment that rewards safety, pharmacovigilance, antimicrobial stewardship, and evidence-based prescribing. BRICS markets combine large dog populations with variable access to advanced therapies, creating opportunities for veterinary education, diagnostic support, and tiered product strategies. G7 countries represent highly sophisticated demand environments with advanced clinic infrastructure and stronger willingness to pay for chronic pet care, while NATO membership overlaps with many high-income markets where veterinary capacity, medicine access, and pet insurance penetration support consistent dermatology care.

Key Country Insights for Canine Atopic Dermatitis Demand

The United States leads demand through high companion animal expenditure, broad adoption of advanced therapeutics, extensive general practice coverage, and access to specialty veterinary dermatologists. Canada follows with strong veterinary standards, growing pet insurance use, and high awareness of chronic allergic skin disease, while Mexico is advancing through urban clinic modernization and wider availability of companion animal medicines. Brazil is Latin America’s key growth engine because of its large pet population, active veterinary pharmaceutical sector, and increasing owner willingness to seek treatment for recurrent pruritus and otitis.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show strong demand for evidence-based dermatology protocols, responsible antimicrobial use, and long-term maintenance options for canine atopic dermatitis, while Russia presents a more complex access environment influenced by distribution, regulatory, and macroeconomic factors. China and India offer substantial long-term potential as pet ownership, middle-class spending, and clinic capacity expand, although access to specialty dermatology remains uneven. Japan, Australia, and South Korea are mature Asia-Pacific markets where premium pet care, preventive medicine, high clinical standards, and specialist referral networks support adoption of advanced canine atopic dermatitis solutions.

Actionable Recommendations for Industry Leaders

Industry leaders should invest in therapies and support programs that address the full canine atopic dermatitis journey, from diagnosis and flare control to long-term maintenance. Commercial success will depend on demonstrating rapid itch reduction, sustained safety, compatibility with multimodal care, reduced reliance on repeated corticosteroid use, and measurable improvement in owner-perceived quality of life.

Organizations should strengthen veterinary education, digital adherence programs, real-world evidence generation, and region-specific access models. Partnerships with dermatology specialists, diagnostic laboratories, telehealth platforms, continuing education providers, and pet insurance stakeholders can improve treatment continuity and differentiate solutions in an increasingly outcomes-driven companion animal dermatology market.

Research Methodology

This executive summary is based on a structured assessment of veterinary dermatology practice patterns, regulatory context, therapeutic innovation, companion animal health trends, and regional demand dynamics. The analysis prioritizes evidence from recognized veterinary clinical guidance, approved therapeutic categories, peer-reviewed dermatology literature, pharmacovigilance principles, and observable shifts in pet healthcare delivery.

The methodology evaluates demand drivers, treatment pathways, adoption barriers, competitive positioning, access conditions, and geographic growth signals without applying market estimation, market sizing, market share, or forecasting. Insights were triangulated across clinical, commercial, regulatory, and operational factors to produce the view of the canine atopic dermatitis market.

Conclusion

The canine atopic dermatitis market is moving toward personalized, long-term disease control supported by targeted drugs, biologics, diagnostics, nutrition, medicated topicals, allergen-specific immunotherapy, and digital engagement. The strongest opportunities will favor organizations that help veterinarians manage a chronic, relapsing condition with consistent outcomes and practical workflows.

As pet owners demand safer, faster, and more convenient dermatology care, industry leaders must combine scientific credibility with access planning, veterinary education, and client adherence strategies. Organizations that align innovation with real-world veterinary practice will be best positioned to support sustainable growth in canine atopic dermatitis care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Canine Atopic Dermatitis Market, by Product Type
7.1. Introduction
7.2. Nutraceuticals
7.2.1. Omega-3 fatty Acids
7.2.2. Omega-6 fatty Acids
7.2.3. Probiotics
7.3. Glucocorticoids
7.3.1. Prednisone
7.3.2. Prednisolone
7.3.3. Dexamethasone
7.4. Immunosuppressants
7.4.1. Cyclosporine
7.4.2. Tacrolimus
7.4.3. Azathioprine
7.5. Antihistamines
7.5.1. Diphenhydramine
7.5.2. Chlorpheniramine
7.5.3. Hydroxyzine
7.6. Monoclonal Antibodies (MAbs)
7.7. Topical Therapies
7.7.1. Corticosteroid Creams
7.7.2. Antibacterial Shampoos
8. Canine Atopic Dermatitis Market, by Route of Administration
8.1. Introduction
8.2. Oral
8.3. Injectable
9. Canine Atopic Dermatitis Market, by Indication
9.1. Introduction
9.2. Environmental Allergens
9.2.1. Pollen
9.2.2. Dust Mites
9.3. Food Allergies
9.4. Flea Allergy Dermatitis
9.5. Seasonal Allergies
10. Canine Atopic Dermatitis Market, by Age Group
10.1. Introduction
10.2. Puppies
10.3. Adult Dogs
10.4. Senior Dogs
11. Canine Atopic Dermatitis Market, by Distribution Channel
11.1. Introduction
11.2. Online
11.3. Offline
11.3.1. Veterinary Hospitals & Clinics
11.3.2. Pet Specialty Stores
12. Canine Atopic Dermatitis Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Canine Atopic Dermatitis Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Canine Atopic Dermatitis Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AB Science SA
16.2. AbbVie, Inc.
16.3. Agrolabo SpA
16.4. Bimeda, Inc.
16.5. Bioceltix JSC
16.6. Bioiberica S.A.U.
16.7. Boehringer Ingelheim International GmbH
16.8. Ceva Santé Animale
16.9. Dechra Pharmaceuticals PLC
16.10. Elanco Animal Health Incorporated
16.11. Farnam Companies, Inc.
16.12. IDEXX Laboratories, Inc.
16.13. Incyte Corporation
16.14. Kemin Industries, Inc.
16.15. LEO Pharma A/S
16.16. Merck & Co. Inc.
16.17. Natural Dog Company
16.18. Nextmune
16.19. Nippon Zenyaku Kogyo Co., Ltd.
16.20. Novartis AG
16.21. Ourofino Animal Health
16.22. Pet King Brands LLC
16.23. Phibro Animal Health Corporation
16.24. Regeneron Pharmaceuticals, Inc
16.25. Vetoquinol S.A.
16.26. Virbac Corporation
16.27. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL CANINE ATOPIC DERMATITIS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CANINE ATOPIC DERMATITIS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CANINE ATOPIC DERMATITIS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CANINE ATOPIC DERMATITIS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CANINE ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL CANINE ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CANINE ATOPIC DERMATITIS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL NUTRACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL NUTRACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL OMEGA-3 FATTY ACIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL OMEGA-3 FATTY ACIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL OMEGA-3 FATTY ACIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL OMEGA-6 FATTY ACIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL OMEGA-6 FATTY ACIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL OMEGA-6 FATTY ACIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL PROBIOTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL PROBIOTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL PROBIOTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL GLUCOCORTICOIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL GLUCOCORTICOIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL GLUCOCORTICOIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PREDNISONE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PREDNISONE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PREDNISONE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL PREDNISOLONE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL PREDNISOLONE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL PREDNISOLONE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL DEXAMETHASONE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL DEXAMETHASONE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL DEXAMETHASONE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL IMMUNOSUPPRESSANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL IMMUNOSUPPRESSANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL IMMUNOSUPPRESSANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CYCLOSPORINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CYCLOSPORINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL CYCLOSPORINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL TACROLIMUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL TACROLIMUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL TACROLIMUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL AZATHIOPRINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL AZATHIOPRINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL AZATHIOPRINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL ANTIHISTAMINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL ANTIHISTAMINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ANTIHISTAMINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL DIPHENHYDRAMINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL DIPHENHYDRAMINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL DIPHENHYDRAMINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CHLORPHENIRAMINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CHLORPHENIRAMINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CHLORPHENIRAMINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL HYDROXYZINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL HYDROXYZINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL HYDROXYZINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MONOCLONAL ANTIBODIES (MABS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL MONOCLONAL ANTIBODIES (MABS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL MONOCLONAL ANTIBODIES (MABS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL TOPICAL THERAPIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL TOPICAL THERAPIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL TOPICAL THERAPIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL CORTICOSTEROID CREAMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL CORTICOSTEROID CREAMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CORTICOSTEROID CREAMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ANTIBACTERIAL SHAMPOOS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ANTIBACTERIAL SHAMPOOS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ANTIBACTERIAL SHAMPOOS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL ENVIRONMENTAL ALLERGENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ENVIRONMENTAL ALLERGENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ENVIRONMENTAL ALLERGENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL POLLEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL POLLEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL POLLEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL DUST MITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL DUST MITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL DUST MITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL FOOD ALLERGIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL FOOD ALLERGIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL FOOD ALLERGIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL FLEA ALLERGY DERMATITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL FLEA ALLERGY DERMATITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL FLEA ALLERGY DERMATITIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL SEASONAL ALLERGIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL SEASONAL ALLERGIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL SEASONAL ALLERGIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL PUPPIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL PUPPIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL PUPPIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL ADULT DOGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL ADULT DOGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ADULT DOGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL SENIOR DOGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL SENIOR DOGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL SENIOR DOGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL PET SPECIALTY STORES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL PET SPECIALTY STORES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL PET SPECIALTY STORES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 127. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 129. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 130. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 131. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 132. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 133. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 134. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 135. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 136. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 137. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 138. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 139. EUROPE CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 151. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 152. NORTH AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 156. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 157. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 164. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 166. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 168. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 169. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 170. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 171. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 172. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 173. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 174. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 175. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 176. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 177. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 178. AFRICA CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 185. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 186. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 187. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 188. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 189. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 192. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 193. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 195. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 196. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 197. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 198. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 199. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 200. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 201. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 202. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 203. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 204. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 205. NATO CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 206. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 207. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 208. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 209. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 210. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 211. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 212. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 213. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 214. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 215. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 216. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 217. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 218. G7 CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 219. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 220. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 221. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 222. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 223. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 224. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 225. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 226. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 227. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 228. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 229. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 230. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 231. BRICS CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 245. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 246. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 247. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 248. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 249. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 250. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 251. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 252. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 253. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 254. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 255. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 256. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 257. ASEAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 258. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 259. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 260. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 261. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 262. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 263. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 264. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 265. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 266. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 267. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 268. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 269. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 270. GCC CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 271. GLOBAL CANINE ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 272. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 274. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 275. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 276. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 277. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 278. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 279. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 280. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 281. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 282. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 283. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 284. CHINA CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 298. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 299. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 300. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 301. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 302. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 303. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 304. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 305. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 306. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 307. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 308. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 309. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 310. JAPAN CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 311. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 313. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 314. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 315. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 316. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 317. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 318. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 319. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 320. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 321. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 322. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 323. INDIA CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 324. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 325. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 326. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 327. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 328. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 329. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 330. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 331. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 332. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 333. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 334. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 335. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 336. GERMANY CANINE ATOPIC DERMATITIS MARKET SIZE, BY OFFLINE, 2017-2032 (USD MILLION)
TABLE 337. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 338. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 339. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY NUTRACEUTICALS, 2017-2032 (USD MILLION)
TABLE 340. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY GLUCOCORTICOIDS, 2017-2032 (USD MILLION)
TABLE 341. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2017-2032 (USD MILLION)
TABLE 342. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, 2017-2032 (USD MILLION)
TABLE 343. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL THERAPIES, 2017-2032 (USD MILLION)
TABLE 344. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 345. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 346. UNITED KINGDOM CANINE ATOPIC DERMATITIS MARKET SIZE, BY ENVIRONMENTAL ALLERGENS, 2017-2032 (USD MILLION)
TABLE 347. UNITED KINGDOM CANINE ATOPIC DERMATITI

Companies Mentioned

  • AB Science SA
  • AbbVie, Inc.
  • Agrolabo SpA
  • Bimeda, Inc.
  • Bioceltix JSC
  • Bioiberica S.A.U.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Farnam Companies, Inc.
  • IDEXX Laboratories, Inc.
  • Incyte Corporation
  • Kemin Industries, Inc.
  • LEO Pharma A/S
  • Merck & Co. Inc.
  • Natural Dog Company
  • Nextmune
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Novartis AG
  • Ourofino Animal Health
  • Pet King Brands LLC
  • Phibro Animal Health Corporation
  • Regeneron Pharmaceuticals, Inc
  • Vetoquinol S.A.
  • Virbac Corporation
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.83 Billion
Forecasted Market Value ( USD ) by 2032 $ 7 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Canine Atopic Dermatitis - Global Strategic Business Report - Product Image

Canine Atopic Dermatitis - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Canine Atopic Dermatitis Market Report 2026 - Product Image

Canine Atopic Dermatitis Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2026-2034 - Product Image

Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2026-2034

  • Report
  • 141 Pages
  • Global
From
Canine Atopic Dermatitis Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Canine Atopic Dermatitis Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Canine Atopic Dermatitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Canine Atopic Dermatitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 185 Pages
  • Global
From

About the Canine Atopic Dermatitis Market

Canine Atopic Dermatitis (CAD) is a common skin condition in dogs that is caused by an allergic reaction to environmental allergens such as pollen, dust mites, and mold. Symptoms of CAD include itching, redness, and hair loss. Treatment of CAD typically involves the use of anti-inflammatory medications, topical treatments, and allergen-specific immunotherapy. The Animal Healthcare/Veterinary market for CAD is growing as pet owners become more aware of the condition and its treatments. Veterinary clinics are increasingly offering CAD treatments, and the market for CAD treatments is expected to continue to grow. Companies in the Canine Atopic Dermatitis market include Zoetis, Merck Animal Health, Elanco Animal Health, and Bayer Animal Health. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.